Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cellular Therapeutics Holdings Ltd Innovative currently holds 2,857,500 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cellular Therapeutics Holdings Ltd Innovative has been a net neutral trader of LYEL stock. They have purchased $0 and sold $0 worth of shares.
Cellular Therapeutics Holdings Ltd Innovative's most recent insider trade was on Jun 29, 2026, when they sold 76,000 shares at $0.00 per share.
Cellular Therapeutics Holdings Ltd Innovative serves as Executive at Lyell Immunopharma, Inc. (LYEL). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Cellular Therapeutics Holdings Ltd Innovative holds the position of Executive at Lyell Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Cellular Therapeutics Holdings Ltd Innovative has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cellular Therapeutics Holdings Ltd Innovative was on Jun 29, 2026, when they sold $0 worth of LYEL shares. This transaction involved 76,000 shares at N/A per share.
Cellular Therapeutics Holdings Ltd Innovative currently owns 2,857,500 shares of Lyell Immunopharma, Inc. (LYEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cellular Therapeutics Holdings Ltd Innovative's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cellular Therapeutics Holdings Ltd Innovative has 2 Form 4 filings on record as an insider at Lyell Immunopharma, Inc..
Set alerts for Cellular Therapeutics Holdings Ltd Innovative and 40,000+ other insiders.